Ma ammaanaan daaweynta neefta?
Maamulka Cuntada iyo Dawooyinka ee Maraykanka (FDA) ayaa digniin ka bixiyay bukaanka qaadaya daawooyinka sida Dulera, Advair, Symbicort, Breo, Foradil, iyo Serevent. Mid ka mid ah daraasadda, tijaabada SMART, ayaa muujisay halis dheeraad ah oo dhimasho ah oo ka timaadda neefta iyo dhibaatooyinka kale ee neefta marka la barbardhigo bukaanka lagu daaweeyo bukaanka qaadaya Serevent, gaar ahaan dadka bukaanka ah ee Afrikaanka ah.
Sababtaan awgeed, FDA waxay u xilsaartay digniin madow oo loogu talagalay daawooyinkan, heerka digniinta ugu sareysa ee daawada ay FDA siin karto.
Serevent iyo Foradil waa kuwa beta-agonists oo dheer (LABAs) loo isticmaalo daaweynta neefta dhexdhexaad ah iyo mid daran. LABAs Maqnaanshaha daaweynaha ku filan oo loogu talagalay neefta, waxayna keeni kartaa weerarro halis ah oo nacas ah haddii loo isticmaalo kaligiis. Qofka qaba neefta, waa inuu had iyo jeer isticmaalaa corticosteroid (sida Flowent, Pulmicort, QVAR) ee daaweynta neefta marka loo baahdo LABA. Dulera, Advair, Breo, iyo Symbicort waxay ka kooban yihiin steroid neefta iyo LABA.
Nasiib darro, tijaabinta SMART ma aysan sheegin in bukaan gaar ah uu qaadanayay corticosteroid neefsashada neefta - taasi waxay gebi ahaan go'aanka dhakhtarka bukaan-socodka ah. Badi dadka bukaanka qaba neefta ugu daran waxay ka qaadeen corticosteroid neefsashada marka la dhigo LABA.
Marka daraasaddu ay eegtay bukaannada qaadatay corticosteroid oo ku neefsanaya iyo LABA (sida Dulera, Advair, Symbicort iyo Breo), uma muuqan inay halis dheeraad ah ugu jiraan neefta daran ama dhimashada xiiqda.
FDA hadda waxay sheegaysaa in daawada LABA aan loo isticmaalin haddii qof qaba neefta ay kantaroolaan corticosteroid oo keli ah.
Haddii neefta aan lagu xakamaynin steroid la neefsado, dooro daaweyn oo dheeraad ah waxaa ka mid ah: (a) kordhinta qiyaasta corticosteroid-ka la-qabsashada (oo laga yaabo inay leedahay khatarteeda ) ama (b) ku darida daawooyinka kale sida LABA, Singulair , theophylline, oral prednisone iyo / ama Xolair . Maskaxda ku hay in neefta aan la daaweynin ay leedahay khatarteeda gaarka ah, oo ay ku jiri karto mid daran, oo halis ku ah nafta halista ah .
Dadka intooda ugu badan, faa'iidooyinka corticosteroid ee la neefsado iyo dawooyinka LABA (Dulera, Advair, Breo, iyo Symbicort) ayaa aad uga culus halista. Si kastaba ha ahaatee, waxaa muhiim ah inaad ogaatid halista iyo faa'iidooyinka daawooyinkan si aad u sameyso doorasho aad ku ogaan karto. Haddii aad horey u isticmaashay daawada LABA oo qayb ka ah daaweynta neeftaada oo aad ka walaacsan tahay xogta kor ku xusan, fadlan haka joojin qaadashada dawadaada neeftaada intaadan la hadlin dhakhtarkaaga. Haddii aad doorato inaadan isticmaalin LABA oo qayb ka ah daaweynta asmada, fadlan u sheeg dhakhtarkaaga go'aankaan ka hor inta aadan joojin daawooyinka asmadaada.
Eeg warqadaha digniinta FDA ee daawooyinka ay ku jiraan LABAs.
> Ilo:
> Aaronson DW. "Black Box" Digniin iyo Daroogada Xasaasiga ah. J Allergy Clin Immunol. 2006; 117: 40-4.Nelson HS, Weiss ST, Bleeker ER, et al. Salmeterol Kombiyuutarka Salmeterol Kombiyuutarka. Laabta. 2006; 129: 15-26.
> Nelson HS. Beta-Agonistayaasha Hawlgabka Mudda dheer ee Dhakhaatiirta: Astaamaha in Mukhaadaradaani Badbaadsan yihiin. Daabacaadda Daryeelka Asaasiga ah ee Asaasiga ah. 2006; 15: 271-77.